Charles Schwab’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-273,002
| Closed | -$1.15M | – | 3756 |
|
2023
Q1 | $1.15M | Buy |
273,002
+2,901
| +1% | +$12.2K | ﹤0.01% | 2691 |
|
2022
Q4 | $1.62M | Buy |
270,101
+12,405
| +5% | +$74.6K | ﹤0.01% | 2626 |
|
2022
Q3 | $1.5M | Buy |
257,696
+16,684
| +7% | +$97.1K | ﹤0.01% | 2664 |
|
2022
Q2 | $1.44M | Buy |
241,012
+203,516
| +543% | +$1.22M | ﹤0.01% | 2662 |
|
2022
Q1 | $176K | Hold |
37,496
| – | – | ﹤0.01% | 3327 |
|
2021
Q4 | $93K | Hold |
37,496
| – | – | ﹤0.01% | 3443 |
|
2021
Q3 | $111K | Buy |
37,496
+17,496
| +87% | +$51.8K | ﹤0.01% | 3370 |
|
2021
Q2 | $50K | Hold |
20,000
| – | – | ﹤0.01% | 3371 |
|
2021
Q1 | $59K | Hold |
20,000
| – | – | ﹤0.01% | 3424 |
|
2020
Q4 | $65K | Buy |
+20,000
| New | +$65K | ﹤0.01% | 3340 |
|
2019
Q2 | – | Sell |
-95,500
| Closed | -$93K | – | 3333 |
|
2019
Q1 | $93K | Hold |
95,500
| – | – | ﹤0.01% | 3095 |
|
2018
Q4 | $71K | Hold |
95,500
| – | – | ﹤0.01% | 3113 |
|
2018
Q3 | $207K | Sell |
95,500
-14,337
| -13% | -$31.1K | ﹤0.01% | 3073 |
|
2018
Q2 | $547K | Buy |
+109,837
| New | +$547K | ﹤0.01% | 2777 |
|
2016
Q2 | – | Sell |
-39,370
| Closed | -$210K | – | 3224 |
|
2016
Q1 | $210K | Buy |
39,370
+9,620
| +32% | +$51.3K | ﹤0.01% | 2886 |
|
2015
Q4 | $366K | Buy |
29,750
+10,670
| +56% | +$131K | ﹤0.01% | 2784 |
|
2015
Q3 | $279K | Hold |
19,080
| – | – | ﹤0.01% | 2860 |
|
2015
Q2 | $373K | Hold |
19,080
| – | – | ﹤0.01% | 2789 |
|
2015
Q1 | $346K | Hold |
19,080
| – | – | ﹤0.01% | 2779 |
|
2014
Q4 | $451K | Hold |
19,080
| – | – | ﹤0.01% | 2657 |
|
2014
Q3 | $462K | Hold |
19,080
| – | – | ﹤0.01% | 2619 |
|
2014
Q2 | $537K | Hold |
19,080
| – | – | ﹤0.01% | 2598 |
|
2014
Q1 | $649K | Buy |
19,080
+3,020
| +19% | +$103K | ﹤0.01% | 2488 |
|
2013
Q4 | $309K | Hold |
16,060
| – | – | ﹤0.01% | 2794 |
|
2013
Q3 | $267K | Hold |
16,060
| – | – | ﹤0.01% | 2804 |
|
2013
Q2 | $160K | Buy |
+16,060
| New | +$160K | ﹤0.01% | 2978 |
|